2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Biomarkers Market?

The surge in instances of heart diseases is predicted to boost the progression of the biomarkers market throughout the forecast period. The employment of biomarkers for patients suffering from cardiac issues has risen exponentially in the recent past. As of now, natriuretic peptides are the most utilized biomarker, aiding in diagnosing heart failure patients. High-sensitivity C-reactive protein and other circulating biomarkers are deployed for identifying heart failure. Among various races and ethnic groups in the USA, heart disease is counted as the leading cause of demise. This escalation in heart disease instances will fuel the need for biomarkers. For example, a report issued by the American College of Cardiology, a US-based non-profitable medical institution, in August 2022, predicts that all four cardiovascular risk factors will witness a rise from 2025 to 2060 in the United States. According to the report, diabetes is expected to have the largest percentage upturn of 39.3%, amounting to 55 million people, followed by dyslipidemia (27.6% reaching 126 million), hypertension (25.1% escalating to 162 million), and obesity (18.3% amounting to 126 million). It was also observed by the researchers that the maximum projected increments in cardiovascular disease rates were in the case of stroke (33.8% reaching 15 million) and heart failure (33.4% touching 13 million), followed by ischemic heart disease (30.7% rising to 29 million) and heart attack (16.9% resulting in 16 million). Due to the surge in heart diseases and related deaths, an upward trend for the growth of the biomarkers is projected.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

#What is the Growth Potential of the Biomarkers Market, and How Will It Perform by 2034?

In recent years, the size of the biomarkers market has seen significant growth. It is expected to expand from a size of $68.77 billion in 2024 to reach $78.14 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. Factors contributing to this growth during the historical period include betterments in genomics and proteomics technologies, a rise in the occurrence of chronic diseases, a heightened focus on personalized medicine, an increased need for companion diagnostics, and a broadening of applications within drug development.

The size of the biomarkers market is predicted to show a swift expansion in the upcoming years, growing to a staggering $135.14 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%. The surge in this period is due to the increasing emphasis on early prevention and detection of diseases, the broadening scope of biomarkers in oncology and immunotherapy, mounting investment in precision medicine, the rise of liquid biopsy as a non-invasive method to detect biomarkers, and the growing use of biomarkers in drug discovery and development. Predicted trends in this forecast period encompass the advancement of multi-biomarker panels, the emergence of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the incorporation of real-world data into biomarker research, and the investigation into microbiome-based biomarkers.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

What Are the Most Significant Market Trends Transforming theBiomarkers Market?

Leading corporations in the biomarker sector are working to create innovative solutions, such as a groundbreaking biological marker. Their focus is on fostering innovation via collaborative research, integrating technology, and delivering strong clinical validation. A groundbreaking biological marker represents a newly discovered criterion that mirrors biological activities and aids in the detection or tracking of diseases. It could be a molecule, gene, or cellular characteristic with potential importance in personalized medicine. In September 2024, a computational precision medicine company based in the US, Genialis, introduced a first-of-its-kind biomarker. This pioneering biomarker amplifies predictive precision for patients’ responses to KRAS inhibitors, thus facilitating personalized treatment schedules and enhancing clinical results. It also bolsters efficient drug development and streamlines patient selection for targeted treatments due to its wide application across various cancer types.

What Are the Top Market Players Propelling the Growth of theBiomarkers Industry?

Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Which Primary Segments of the Biomarkers Market Are Driving Growth and Industry Transformations?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Biomarkers Market?# Market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Biomarkers Maret 2025, By The Business Research Company:

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/biologics-market

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Dermatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: